Dihexa 5 mg
Peptides

Dihexa 5 mg

Product Details Dragon Pharma
Active Substance Dihexa Angiotensin IV-derived peptide analog
Strength 5 mg per vial
Package 1 × 2 mL vial 5 mg labeled content
Form Lyophilized powder
Research Class Nootropic research compound
Research Target HGF / c-Met pathway
Human Half-Life Not established
Development Status Experimental
Out of stock

Dragon Pharma DIHEXA 5 mg – Advanced Nootropic Peptide for Cognitive Research

Dragon Pharma DIHEXA 5 mg is a research-grade peptide developed for scientific exploration of cognitive performance and neurological health. Chemically known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, DIHEXA is a synthetic compound derived from the angiotensin IV pathway and designed to support advanced studies related to synaptogenesis and neural signaling.

Unlike many compounds commonly used in fitness research, DIHEXA 5 mg focuses on mechanisms associated with the central nervous system. Researchers have shown interest in this peptide due to its ability to cross the blood-brain barrier and interact with pathways connected to neuronal growth and repair. Because of this unique profile, Dragon Pharma DIHEXA has attracted attention in experimental studies investigating memory, cognitive resilience, and neuroprotective signaling.

Each vial contains 5 mg of high-purity lyophilized DIHEXA in a sterile 2 mL vial. The freeze-dried format ensures stability during storage and allows precise reconstitution for controlled laboratory protocols. Researchers interested in the biological mechanisms behind neural growth factors may also explore literature describing the HGF/c-Met signaling system, which is frequently discussed in relation to DIHEXA activity.

Effects

In laboratory research environments, DIHEXA has been investigated for its potential to support neural connectivity and brain signaling pathways. Studies suggest the compound may influence processes linked to synaptic formation and neuronal communication.

Because of these properties, research involving Dragon Pharma DIHEXA 5 mg often focuses on areas such as:

  • Synaptic development and neural plasticity
  • Cognitive signaling pathways
  • Memory and learning mechanisms
  • Neuroprotective responses under cellular stress

For athletes and fitness researchers, cognitive clarity and neural recovery are increasingly studied alongside physical performance. Compounds like DIHEXA may therefore be explored in broader research frameworks involving training adaptation and neurological recovery.

Technical Details

Compound Type
Angiotensin IV-Derived Peptidomimetic
Structural Origin
NleΒΉ-Angiotensin IV Analogue
Molecular Formula
C₂₇Hβ‚„β‚„Nβ‚„Oβ‚…
Molecular Weight
504.7 g/mol
CAS Number
1401708-83-5
PubChem CID
129010512
Research Target
HGF / c-Met System
Research Mechanism
HGF-Dependent c-Met Signaling
Development Status
Experimental / Preclinical

Dosage & Usage Guidelines

As a research peptide, DIHEXA 5 mg is typically studied in carefully controlled experimental protocols. Due to its high potency and metabolic stability, laboratory research commonly evaluates daily administration ranges between 5 mg and 10 mg, depending on the experimental design.

The peptide is supplied as a lyophilized powder and requires proper reconstitution using bacteriostatic water before use in laboratory environments. Standard sterile handling techniques should always be followed when preparing peptide solutions.

Because DIHEXA has a relatively long metabolic stability compared with many peptides, research protocols often involve once-daily dosing schedules.

Cycle

Research involving Dragon Pharma DIHEXA is often structured over extended observation periods. Experimental cycles commonly range from 4 to 8 weeks, allowing researchers to evaluate long-term effects related to synaptic signaling and neural adaptation.

Since DIHEXA is a non-hormonal peptide and does not interact with androgenic or estrogenic pathways, it does not influence endocrine systems in the same way anabolic steroids do. Because of this, post-cycle therapy protocols are generally unnecessary within research frameworks.

In broader peptide research programs, investigators may study DIHEXA alongside regenerative compounds. For example, combining cognitive and recovery research could involve peptides such as BPC 157 to explore complementary mechanisms of neural and tissue repair. Metabolic regulators like Tirzepatide 10 mg may also be evaluated within comprehensive research protocols examining metabolic and neurological interactions.

Possible Side Effects

As with any experimental compound, DIHEXA should be handled with caution in laboratory environments. Available research suggests the compound demonstrates targeted biological activity, but comprehensive human safety data remains limited.

Possible research observations may include:

  • Localized irritation at the injection site
  • Mild inflammatory responses
  • Potential cellular signaling changes due to growth-factor interaction

DIHEXA is supplied strictly as a research material and is not intended for human consumption. Proper laboratory safety procedures and personal protective equipment should always be used when handling peptide compounds.

Research and Future Directions

Scientific interest in DIHEXA 5 mg continues to grow due to its strong synaptogenic activity and unique interaction with growth factor signaling pathways. Researchers are investigating potential applications in areas such as neurodegeneration models, nerve regeneration, and cognitive adaptation.

Although results vary across experimental models, DIHEXA remains a valuable compound for studying how neural networks form and adapt under different biological conditions. With its high purity and reliable formulation, Dragon Pharma DIHEXA provides a consistent reference material for laboratories exploring advanced peptide science.

Shipping & Product Authenticity

USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 business hours
Tracking
Tracking number provided
Direct Supply & Discreet Delivery

This product is supplied through the official Dragon Pharma distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.

What to Expect

  • βœ” Orders are processed after payment confirmation
  • βœ” USA Domestic shipping is typically faster when local stock is selected
  • βœ” International orders include tracking, though update frequency may vary by destination
  • βœ” Multiple warehouses may result in separate shipments when applicable
Authenticity support: official Dragon Pharma presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
Verified Supply

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions

What is the active substance in DIHEXA 5 mg?

The active compound is N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, commonly known as DIHEXA. It is a synthetic peptide derived from the angiotensin IV pathway and designed for neurological research applications.

What makes DIHEXA different from traditional nootropics?

Unlike stimulant-based nootropics, DIHEXA is studied for its interaction with growth factor signaling pathways that influence synaptic development and neuronal communication.

What is the half-life of DIHEXA?

DIHEXA is metabolically stabilized, which means it remains active longer than many traditional peptides and supports once-daily dosing in research protocols.

Does DIHEXA affect hormones?

No. DIHEXA is not a hormonal compound and does not interact with androgen or estrogen receptors. It is studied primarily for neurological signaling pathways.

How should DIHEXA 5 mg be stored?

The lyophilized powder should be stored in a cool, dry environment away from direct light. Refrigeration between 2–8Β°C is recommended. After reconstitution, the peptide solution should remain refrigerated.

No reviews found

Please log in to write Dihexa 5 mg review.

Related Offers
Lab Tested
Domestic & International
-40% OFF
Selank
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Selank Tuftsin-derived peptide
Strength 10 mg per vial
Package 1 × 2 mL vial 10 mg labeled content
Form Lyophilized powder
Research Class Regulatory peptide
Peptide Type Heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro
Human Half-Life Not established
Research Focus Neuroregulation Anxiolytic & nootropic research
Latest laboratory result 9.74 mg November 20, 2023 · 97.40% of 10 mg label claim · Batch HDSLK923 View
$27.00 $45.00
You will save $18.00
Lab Tested
Domestic & International
-40% OFF
Semax
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Semax ACTH(4–7)-PGP
Strength 5 mg per vial
Package 1 × 2 mL vial 5 mg labeled content
Form Lyophilized powder
Research Class Regulatory peptide ACTH-derived peptide
Peptide Type Heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro
Peptide Half-Life Several minutes
Research Focus Neuroregulation Nootropic & neuroprotective research
Latest laboratory result 5.20 mg November 20, 2023 · 104.00% of 5 mg label claim · Batch HDSX923 View
$39.00 $65.00
You will save $26.00
Shipped International
-40% OFF
SS-31 50 mg
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Elamipretide SS-31 · MTP-131
Strength 50 mg per vial
Package 1 × 2 mL vial 50 mg labeled content
Form Lyophilized powder
Research Class Mitochondrial peptide
Peptide Type Tetrapeptide Aromatic-cationic peptide
Human Half-Life Not established
Research Target Cardiolipin Inner mitochondrial membrane
$153.00 $255.00
You will save $102.00
Domestic & International
-40% OFF
DSIP 10 mg
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance DSIP Delta Sleep-Inducing Peptide
Strength 10 mg per vial
Package 1 × 2 mL vial 10 mg labeled content
Form Lyophilized powder
Research Class Neuropeptide
Peptide Type Nonapeptide 9 amino acids
Human Half-Life Not established
Development Status Experimental
$51.00 $85.00
You will save $34.00

Add to Cart - Product(s)

Close Button
Empty

Total Cost: